 Ali Zirakzadeh
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Offenses | 3 | 2010 | 148 | 0.670 |
Why?
| | Vancomycin Resistance | 2 | 2006 | 15 | 0.560 |
Why?
| | Enterococcus | 2 | 2006 | 18 | 0.550 |
Why?
| | Gram-Positive Bacterial Infections | 2 | 2006 | 67 | 0.520 |
Why?
| | Methadone | 1 | 2013 | 69 | 0.430 |
Why?
| | Smoking Cessation | 2 | 2013 | 360 | 0.360 |
Why?
| | Somatoform Disorders | 1 | 2009 | 38 | 0.350 |
Why?
| | Smoking | 2 | 2013 | 1487 | 0.320 |
Why?
| | Opioid-Related Disorders | 1 | 2013 | 417 | 0.270 |
Why?
| | Glycopeptides | 1 | 2005 | 58 | 0.260 |
Why?
| | Mental Disorders | 2 | 2010 | 939 | 0.260 |
Why?
| | DNA, Bacterial | 1 | 2006 | 314 | 0.250 |
Why?
| | Nicotinic Agonists | 2 | 2013 | 110 | 0.180 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 56 | 0.160 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 112 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2018 | 211 | 0.130 |
Why?
| | Prevalence | 2 | 2013 | 2326 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 359 | 0.130 |
Why?
| | Narcotics | 1 | 2013 | 50 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 610 | 0.110 |
Why?
| | Behavior, Addictive | 1 | 2013 | 77 | 0.110 |
Why?
| | Drug Interactions | 1 | 2013 | 352 | 0.100 |
Why?
| | Lymph Nodes | 1 | 2013 | 455 | 0.100 |
Why?
| | Nicotine | 1 | 2013 | 276 | 0.090 |
Why?
| | Epidemiologic Research Design | 1 | 2010 | 30 | 0.090 |
Why?
| | Benzazepines | 1 | 2009 | 38 | 0.090 |
Why?
| | Quinoxalines | 1 | 2009 | 62 | 0.090 |
Why?
| | Feeding and Eating Disorders | 1 | 2010 | 125 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2013 | 770 | 0.080 |
Why?
| | Violence | 1 | 2010 | 218 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2018 | 3171 | 0.080 |
Why?
| | beta-Defensins | 1 | 2007 | 22 | 0.080 |
Why?
| | Odds Ratio | 1 | 2010 | 996 | 0.080 |
Why?
| | Plasma Cells | 1 | 2007 | 59 | 0.070 |
Why?
| | Suicide, Attempted | 1 | 2010 | 316 | 0.070 |
Why?
| | Anxiety Disorders | 1 | 2010 | 309 | 0.070 |
Why?
| | Sleep Wake Disorders | 1 | 2010 | 241 | 0.070 |
Why?
| | Epilepsy | 1 | 2010 | 290 | 0.070 |
Why?
| | Survivors | 1 | 2009 | 418 | 0.070 |
Why?
| | Colitis, Ulcerative | 1 | 2007 | 105 | 0.070 |
Why?
| | Colony Count, Microbial | 1 | 2006 | 120 | 0.070 |
Why?
| | Latin America | 1 | 2005 | 74 | 0.070 |
Why?
| | Colon | 1 | 2007 | 238 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2010 | 765 | 0.070 |
Why?
| | North America | 1 | 2005 | 266 | 0.060 |
Why?
| | Humans | 10 | 2018 | 118972 | 0.060 |
Why?
| | Crohn Disease | 1 | 2007 | 197 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2010 | 2513 | 0.060 |
Why?
| | Population Surveillance | 1 | 2005 | 413 | 0.050 |
Why?
| | Depression | 1 | 2010 | 1132 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2013 | 9342 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2275 | 0.050 |
Why?
| | Neoplasms | 1 | 2013 | 2179 | 0.040 |
Why?
| | Muscle Neoplasms | 1 | 2018 | 8 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 462 | 0.040 |
Why?
| | Risk Factors | 1 | 2010 | 9000 | 0.040 |
Why?
| | United States | 1 | 2013 | 12555 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2005 | 1510 | 0.030 |
Why?
| | Male | 5 | 2018 | 57801 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 627 | 0.030 |
Why?
| | Female | 5 | 2018 | 61564 | 0.030 |
Why?
| | Adult | 3 | 2010 | 31512 | 0.030 |
Why?
| | Child | 1 | 2010 | 19129 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4077 | 0.020 |
Why?
| | Varenicline | 1 | 2009 | 21 | 0.020 |
Why?
| | Drug Labeling | 1 | 2009 | 45 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2010 | 403 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 27617 | 0.020 |
Why?
| | Microscopy, Immunoelectron | 1 | 2007 | 45 | 0.020 |
Why?
| | Tobacco Use Disorder | 1 | 2009 | 233 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 310 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1868 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 412 | 0.020 |
Why?
| | Logistic Models | 1 | 2010 | 1901 | 0.020 |
Why?
| | Aged | 2 | 2018 | 19657 | 0.020 |
Why?
| | Sex Factors | 1 | 2010 | 1781 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 982 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2010 | 2874 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 531 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2007 | 745 | 0.010 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 1137 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2009 | 1798 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2007 | 6561 | 0.010 |
Why?
|
|
Zirakzadeh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|